Regal Investment Fund (ASX:RF1) Announces Half-Year Results and $104.4m Capital Raising
Regal Investment Fund (ASX:RF1) reports a 34% rise in operating profit and completes a $104.4 million capital raising for the half-year ended December 2024.
Acrux (ASX:ACR) Reports A$20M Revenue and Announces US Product Launches
Acrux (ASX:ACR) reports A$20 million revenue for FY23-FY24 and announces new US product launches, bolstering its presence in the pharmaceutical market.
Besra Gold Inc (ASX:BEZ) Addresses Unauthorised Communications
Besra Gold Inc (ASX:BEZ) addresses unauthorised statements from Quantum Metals, clarifying gold resource figures and operational integrity.
Archer Materials Limited (ASX:AXE) Enhances Biochip Feasibility and Advances Development Roadmap
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.
Dimerix Limited (ASX:DXB) Reports Half-Year Financial Results
Dimerix Limited (ASX:DXB) reports a 113% revenue increase in the half-year ended December 2024, alongside a 93% rise in losses.
Titomic Limited (ASX:TTT) Expands US Operations with Huntsville Acquisition
Titomic Limited (ASX:TTT) expands US operations by acquiring a Huntsville facility, securing financing, and enhancing manufacturing capabilities.
Great Boulder Resources (ASX:GBR) Unveils New Shallow Gold Zones at Side Well South
Great Boulder Resources (ASX:GBR) unveils new shallow gold zones at Side Well South with significant drilling results, enhancing its exploration portfolio.
Reach Resources Limited (ASX:RR1) Confirms Initial Assay Results Impact Securities
Reach Resources Limited (ASX:RR1) confirms initial assay results from Murchison South have a material impact on its securities, ensuring ASX listing compliance.
4DMedical (ASX:4DX) Gains Regulatory Approval for CT LVAS™ in Canada
4DMedical (ASX:4DX) secures Canadian approval for CT LVAS™, expanding its respiratory imaging portfolio and market reach.
4DMedical Limited (ASX:4DX) Launches Share Purchase Plan
4DMedical Limited (ASX:4DX) launches a Share Purchase Plan, enabling shareholders to buy up to $30,000 in new shares without fees.